Skip to main content
SpringerLink
Log in

Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release

  • Short Communication
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The effects of prostaglandin E2 (PGE2) on electrically evoked noradrenaline release in rat brain cortex were studied under conditions under which autoinhibition of release was avoided. When stimulation was carried out with 36 pulses at 3 Hz, 1 μmol/1 PGE2, produced about 50% inhibition of release. In the presence of the α2-adrenoceptor antagonist yohimbine (1 gmol/1) the effect of PGE2 was markedly increased. When release was elicited by 3 pulses/100 Hz the period of stimulation was too short to permit development of autoinhibition by released noradrenaline. Then the concentration-response-curve for PGE2 was very similar to that obtained under the above conditions (36 pulses/3 Hz, in the presence of yohimbine). These data suggest that both the α2-adrenoceptor and the PGE2-receptor are linked to a common pathway. Since indometacin (10 μmol/1) did not enhance evoked transmitter release, an influence of endogenous PG's on in vitro release of noradrenaline from rat brain cortex slices can be excluded.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

PG:

prostaglandin

References

  • Allgaier C, Hertting G, Kügelgen von O (1987) The adenosine receptor-mediated inhibition of noradrenaline release possibly involves a N-protein and is increased by α2-autoreceptor blockade. Br J Pharmacol 90:403–412.

    Google Scholar 

  • Allgaier C, Daschmann B, Sieferling J, Hertting G (1989) Presynaptic κ-opioid receptors on noradrenergic nerve terminals couple to G proteins and interact with the α2-adrenoceptors. J Neurochem (in press).

  • Berchtold-Kanz E, Anhut H, Heldt R, Neufang B, Hertting G (1981) Regional distribution of arachidonic acid metabolites in rat brain following convulsive stimuli. Prostaglandins 22:65–79.

    Google Scholar 

  • Bergström S, Farnebo LO, Fuxe K (1973) Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur J Pharmacol 21: 362–368.

    Google Scholar 

  • Hillier K, Templeton WW (1980) Regulation of noradrenaline overflow in rat cerebral cortex by prostaglandin E2. Br J Pharmacol 70:469–473.

    Google Scholar 

  • Limberger N, Späth L, Starke K (1988) Presynaptic α2-adrenoceptor, opioid κ-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit cortex. NaunynSchmiedeberg's Arch Pharmacol 338:53–61.

    Google Scholar 

  • Reimann W, Steinhauer HB, Hedler L, Starke K, Hertting G (1981) Effect of prostaglandin D2, E2 and F2α on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol 69:421–427.

    Google Scholar 

  • Schlicker E, Fink K, Göthert M (1987) Influence on eicosanoids on serotonin release in the rat brain: inhibition by prostaglandins E1 and E2. Naunyn-Schmiedeberg's Arch Pharmacol 335:646–651.

    Google Scholar 

  • Seregi A, Hertting G (1984) Changes in cyclooxygenase activity and prostaglandin profiles during monoamine metabolism in rat brain homogenates. Prostaglandins Leukotrienes Med 14: 113–121.

    Google Scholar 

  • Starke K, Montel H (1973) Interaction between indomethacin, oxymetazoline and phentolamine on the release of [3H]noradrenaline from brain slices. J Pharm Pharmacol 25:758–759.

    Google Scholar 

  • Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neurons of rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 29:944–949.

    Google Scholar 

  • Valenta B, Drobny H, Singer EA (1988) Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition. J Pharmacol Exp Ther 245:118–121.

    Google Scholar 

  • Wolfe LS (1982) Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, and other derivatives of Carbon-20 unsaturated fatty acids. J Neurochem 38:1–14.

    Google Scholar 

  • Wolfe LS, Rostworowski K, Pappius HM (1976) The endogenous biosynthesis of prostaglandins by brain tissue in vitro. Can J Biochem 54:629–640.

    Google Scholar 

  • Zier G, Drobny H, Valenta B, Singer EA (1988) Evidence against a functional link between noradrenaline uptake mechanism and presynaptic alpha-2 adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 337:118–121.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie und Toxikologie der Universität, Hermann-Herder-Strasse 5, 7800, Freiburg, Federal Republic of Germany

    Clemens Allgaier, Thomas Jäger & Georg Hertting

Authors
  1. Clemens Allgaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georg Hertting
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to C. Allgaier at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allgaier, C., Jäger, T. & Hertting, G. Endogenous noradrenaline impairs the prostaglandin-induced inhibition of noradrenaline release. Naunyn-Schmiedeberg's Arch Pharmacol 340, 472–474 (1989). https://doi.org/10.1007/BF00167051

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00167051

Key words

Search

Navigation